West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts ...

The stock looks like a great pick to help turn investors into multimillionaires, given enough time. Everyone should save ...

Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC platform and consulting services to help pharmaceutical companies manage system ...

ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsBrian Mueller - ...

When MEI Pharma announced it was considering its “strategic alternatives” in the wake of a failed merger last year, the options seemed pretty mundane. But, rather than winding down the company as the ...

In today's Pharmaceutical Executive Daily, Senate Democrats press major pharmaceutical companies for transparency on the terms of their most-favored-nation pricing deals with the Trump administration, ...

In today's Pharmaceutical Executive Daily, the FDA issues new draft guidance aimed at reducing the cost and complexity of biosimilar development, Novo Nordisk responds to an FDA warning letter ...

Pharmaceutical companies in India are driving innovation, biosimilars, APIs & global exports while strengthening research, manufacturing & healthcare access.